Table 1. Expression comparison for MAL2 and TPD52 in tissues of patient with CRC.
| Variable | No. | MAL2 | TPD52 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Negative (%) | Positive (%) | χ2 | p -value | Negative (%) | Positive (%) | χ2 | p -value | ||
| 1 | 46.19 | <0.001* | 61.09 | <0.001* | |||||
| Non-carcerous | 123 | 101(82.1) | 22(17.9) | 98(80.0) | 25(20.0) | ||||
| Primary carcinoma | 123 | 49(39.8) | 74(60.2) | 37(30.1) | 86(69.1) | ||||
| 2 | 0.357 | 0.55 | 0.18 | 0.672 | |||||
| Primary carcinoma | 58 | 17(29.3) | 41(70.7) | 14(24.1) | 44(75.9) | ||||
| Lymph node | 58 | 20(34.5) | 38(65.5) | 16(27.6) | 42(72.4) | ||||
| 3 | 0.076 | 0.782 | 4.145 | 0.042* | |||||
| Primary carcinoma | 38 | 12(31.6) | 26(68.4) | 8(21.1) | 30(78.9) | ||||
| Liver metastasis | 38 | 10(26.3) | 28(73.7) | 2(5.3) | 36(94.7) | ||||
*P < 0.05, statistically significant, Pearson’s X2 test.